510(k) Report

510(k) · Cleared

Cleared

Transvaginal Endoscopy Set

K033728510(k) TraditionalCleared Feb 27, 200491-day reviewClass II21 CFR 884.1640

Data to Oct 25, 2026 (FDA decisions) Oct 12, 2026 (recalls) Sep 30, 2026 (MAUDE) refreshed weekly, last Nov 3, 2026

KARL STORZ Endoscopy-America, Inc. · HEW Culdoscope (And Accessories)

Cleared on Feb 27, 2004 after a 91-day review. The FDA summary names no predicate by number.

Decided
Feb 27, 2004
Review
91 days
Class
Class II
Product code
HEW
Recalls
None
Predicates
0

The FDA summary names no predicate by number.

FIG. 1 — Lineage of K033728Source: FDA 510(k) database · How lineage is built

Get the monthly Device Review Tracker

Notable FDA decisions, review times and new Class I recalls. See an issue.

Sources: FDA 510(k) database (decision fields), the FDA summary (predicates and indications), FDA recall and enforcement reports, and MAUDE; processed by 510(k) Report. Verify on FDA.gov · Methodology and accuracy.

Planning a device in HEW? A 510(k) Report weighs predicate choices, recall history and review times for a new device like this one.

Top candidate predicates for a new HEW device

  1. #1 K243152 GelPOINT V-Path Transvaginal Access Platform…score 11.0 · 4 generations · no Class I recall
  2. #2 Held for the reportin the report
Get a 510(k) Report

What was it cleared against?

The FDA summary names no predicate by number.

What descends from it?

No later submission names this one as a predicate yet.

Has anything in its family been recalled? (0 Class I)

No FDA recall names this device.

No ancestor or descendant has a Class I recall.

How does its category compare?

All HEW devices

HEW Culdoscope (And Accessories): FDA decisions, review times, recalls and adverse event reports over 20 years.

FDA decisions per year · HEW

1in 2025

2011: 12012: 12015: 22016: 12018: 12019: 12020: 12025: 1
2007high 2 (2015) · low 0 (2007)2026

2026 to Oct 25, outlined.

Median 510(k) review, days · HEW

Too few HEW 510(k)s in any year since 2007 to give a median.

Recalls per year · HEW

1in 2018

2018: 1
2007high 1 (2018) · low 0 (2007)2026

Class I (0 since 2007) Class II/III not classified

Adverse event reports per year · HEW

20in 2025

2007: 12008: 12009: 42010: 32011: 32012: 12013: 32014: 22016: 92017: 152018: 142019: 292020: 352021: 142022: 232023: 182024: 322025: 20
2007high 35 (2020) · low 0 (2015)2025

MAUDE reports naming product code HEW, not matched to any one device; reports are not rates.

View these four charts as a table
YearDecisionsMedian 510(k) review, daysRecalls (Class I)MAUDE reports
20070—01
20080—01
20090—04
20100—03
20111—03
20121—01
20130—03
20140—02
20152—00
20161—09
20170—015
20181—114
20191—029
20201—035
20210—014
20220—023
20230—018
20240—032
20251—020
20260—0—

What is it indicated for?

The TVE Set is indicated for use by qualified surgeons during outpatient or clinical endoscopic examination of the female genital tract. This examination method is designed to provide video visual access for endoscopic examination of the vagina, cervix and uterus, and through transvaginal access, illow visualization of both fallopian tubes and the ovaries to perform diagnostic and operative procedures. Indications for use are: * Unexplained pelvic pain…

Read the full statement (113 words)

The TVE Set is indicated for use by qualified surgeons during outpatient or clinical endoscopic examination of the female genital tract. This examination method is designed to provide video visual access for endoscopic examination of the vagina, cervix and uterus, and through transvaginal access, illow visualization of both fallopian tubes and the ovaries to perform diagnostic and operative procedures. Indications for use are:

* Unexplained pelvic pain (acute, chronic)

* Menstrual abnormalities;

* Infertility and sterility;

* Indefinite pelvic mass;

* Ectopic pregnancy;

* Pelvic endometriosis;

* Polycystic ovaries;

* Pelvic inflammatory disease (PID);

* Pain mapping;

* Congenital abnormalities of the pelvic organs;

* Lysis of adhesions;

* Cytology mapping;

* Biopsy.

Indications for use as stated in the FDA summary.

Cite this page

510(k) Report. “K033728: Transvaginal Endoscopy Set.” Lineage record from FDA 510(k) data and the FDA summary. Updated Nov 3, 2026. Accessed Nov 6, 2026. https://510kreport.com/device/K033728

Report an extraction error

Tell us what is wrong; we check it against the FDA summary.

Are you the manufacturer?

Send a correction or an update to this page, for example a newer model or a public statement about a recall.

Record history
  • FDA decision record loaded May 2, 2026
  • Summary read Oct 13, 2026 (extraction version 9eaa42aa01ed)
  • Page last updated Nov 3, 2026